ARVO 2018 says ‘Aloha!’ to Hawaii for annual event
Pre-operative measurements important in IOL decision-makingSurgeons work hard to get happy patients, and satisfied patients spread the word and refer their friends. They don't need extra post-op visits, and can return yearly to see their referring doctor. Selecting the best presbyopia-correcting IOL for a patient is critical and depends on methodical, preoperative decision-making.
Why you should worry about Anthem’s new anesthesia policy
Why you should worry about Anthem’s new anesthesia policyIs this new policy in the patient's best interest?
PALADIN subset finds improvement after 12 months with intravitreal implantAmong a subset of patients in the phase IV PALADIN study, there was improved visual acuity, improved macular thickness, and reduced treatment burden among patients treated with the intravitreal fluocinolone acetonide 0.2 µg (Iluvien implant) for DME.
Intraop wavefront aberrometry may enhance results in toric IOL surgeryFindings of a study determining the prediction error in the magnitude of residual astigmatism after cataract surgery with a toric intraocular lens (IOL) suggest that use of intraoperative wavefront aberrometry for toric power selection could enhance the refractive outcome in a large subset of eyes.
When to consider surgery for ptosisResults of a retrospective study show that simple congenital ptosis, even when the pupil is obstructed, is less amblyogenic than conventionally thought. The study supports correcting refractive error and strabismus before considering ptosis surgery.
Consider risk factors of secondary glaucoma prior to LASIK procedureKnow the patient’s family history of glaucoma, and conduct a comprehensive exam before LASIK procedure. It is crucial to monitor the patient after surgery; watch for interfact cysts, loose flaps, and pressure-induced interlamellar stromal keratitis.
Does dexamethasone implant add benefit in ranibizumab patients?The addition of dexamethasone implant (Ozurdex, Allergan) to a continuing regimen of ranibizumab (Lucentis, Genentech) did not produce results in visual acuity outcomes that differed from those achieved with ranibizumab alone at 6 months. However, there was an improvement in the central macular thickness on OCT in patients.
Distinction between lamellar holes and macular pseudoholesLamellar holes usually don’t require treatment, but it is important to recognize the eyes that may benefit from vitrectomy.
Drug delivery systems could improve poor adherenceJonathan S. Myers, MD, reports that intraocular drug delivery systems could help solve the problem of poor adherence in patients taking glaucoma medications. Implanted in the eye, the systems would allow for glaucoma drugs to gradually dissolve or elute medication.